Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Evelo Biosciences Inc

(NASDAQ: EVLO)
Add to Portfolio
-0.31 (-6.90%)
as of Dec 6, 2019

Values in US Thousands
  12-2018 12-2017 12-2016
Operating Expenses 58,103 27,531 13,025
Operating Income -58,103 -27,531 -13,025
Interest Expense -1,563 215 287
Other Income/Expenses -406 -301 -20
Pre-tax Income -56,946 -28,047 -13,332
Net Income from Cont. Operations -56,946 -28,047 -13,332
Total Net Income $ -56,946 $ -28,047 $ -13,332
Basic EPS from Cont. Ops. -2.60 -7.48 -4.70
Basic EPS from Total Ops. -2.78 -9.10 -5.28
Diluted EPS from Cont. Ops -2.60 -7.48 -4.70
Diluted EPS from Total Operations -2.78 -9.10 -5.28
EBITDA -56,168 -26,697 -12,530